401.HK Stock Analysis
40
Uncovered
Wanjia Group Holdings Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Wanjia Group Holdings Ltd. wholesales and distributes pharmaceutical and healthcare products. The company employs 192 full-time employees The company went IPO on 2013-10-11. The firm mainly operates its business through two segments. The Pharmaceutical Wholesale and Distribution Business segment mainly distributes pharmaceutical products for pharmaceutical retail chain stores, independent pharmacies and outpatient departments of community hospitals and healthcare service stations. The Hemodialysis Treatment and Consultancy Service Business segment mainly provides kidney care services and operates hemodialysis treatment centers.